Generate Biomedicines, Inc. (GENB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Generate Biomedicines, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 |
|---|---|---|
| Valuation | ||
| P/E Ratio | -3.12x | -9.28x |
| P/B Ratio | -1.03x | -3.71x |
| P/S Ratio | 19.87x | 78.80x |
| Profitability | ||
| Gross Margin | 100.0% | 100.0% |
| Operating Margin | -737.0% | -962.6% |
| Net Margin | -637.0% | -849.4% |
| EBITDA Margin | -653.7% | -800.2% |
| Liquidity | ||
| Current Ratio | 2.85x | 4.70x |
| Quick Ratio | 2.85x | 4.70x |
| Leverage | ||
| Debt/Equity | -0.11x | -0.18x |
YoY = year-over-year change. Source: FMP..